Bodies ravaged by cancer and chemotherapy have special needs for care and micronutrition. Tumorous diseases extract their toll on the supply of essential minerals to the tissues. Neoplastically transformed cells are not only under attack by the tumor, but also by the various drugs administered to fight the malignant spread. While these processes are going on, cancer patients are at a much higher risk of being depleted of vital micronutrients like selenium.
Selenium deficiency is associated with worse prognoses even before the initiation of cancer therapy and side effects of cytostatics are lessened when mineral stores in the cancer patient’s body are replenished to healthy levels. Moreover, sodium selenite can protect kidneys and heart among other organs. The new dose charts on various selenase formulations recently updated by biosyn provides guidance on how normal selenium biology can be achieved for prevention and treatment of peri-chemotherapeutic and cancer-associated selenium deficiency. The chart includes a breakdown according to genetic predisposition along with hyperlinks to the pertinent publications.
To access these helpful dose charts, go to: